[S17] Frontiers in Studies on Antiviral Infectious Diseases —Shaping Therapeutic Innovation through Target Molecules—

4:50 PM - 5:10 PM JST(7:50 AM - 8:10 AM UTC)

[S17-1] Drug discovery and development targeting SARS-CoV-2 main protease

○Nobuyo Higashi-Kuwata¹, Shin-ichiro Hattori¹, Naoki Kishimoto², Nobutoki Takamune², Hiromi Ogata-Aoki^1,3, Haydar Bulut⁴, Shogo Misumi², Hirokazu Tamamura⁵, Hiroaki Mitsuya^1,4,6 (1. Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, 2. Graduate School of Pharmaceutical Sciences, Kumamoto University, 3. Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 4. Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 5. Lab. Biomat. Bioeng., Inst. Sci. Tokyo, 6. Kumamoto University Hospital)